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Human Naive CD8 T Cells Down-Regulate Expression of the
WNT Pathway Transcription Factors Lymphoid Enhancer
Binding Factor 1 and Transcription Factor 7 (T Cell Factor-1)
following Antigen Encounter In Vitro and In Vivo1
Tim Willinger,2* Tom Freeman,† Mark Herbert,‡ Hitoshi Hasegawa,§ Andrew J. McMichael,*
and Margaret F. C. Callan¶
The transcription factors lymphoid enhancer binding factor 1 (LEF1) and transcription factor 7 (TCF7) (T cell factor-1 (TCF-1))
are downstream effectors of the WNT signaling pathway, which is a critical regulator of T cell development in the thymus. In this
study, we show that LEF1 and TCF7 (TCF-1) are not only expressed in thymocytes, but also in mature T cells. Our data
demonstrate that Ag encounter in vivo and engagement of the TCR or IL-15 receptor in vitro leads to the down-regulation of LEF1
and TCF7 (TCF-1) expression in human naive CD8 T cells. We further show that resting T cells preferentially express inhibitory
LEF1 and TCF7 (TCF-1) isoforms and that T cell activation changes the isoform balance in favor of stimulatory TCF7 (TCF-1)
isoforms. Altogether, our study suggests that proteins involved in the WNT signaling pathway not only regulate T cell develop-
ment, but also peripheral T cell differentiation. The Journal of Immunology, 2006, 176: 1439–1446.
T he differentiation of T lymphocytes is mainly controlledby signals through their Ag-specific TCR. In the thymus,TCR signals regulate the development of a mature T cell
repertoire via positive and negative selection. In the periphery,
naive T cells (TN)3 further differentiate into effector and memory
T cells when recognizing foreign Ags derived from infectious
pathogens via their TCR (1). Apart from TCR signals and cyto-
kines, other factors contributing to peripheral T cell differentiation
are not well characterized at present.
In addition to TCR signals, major developmental pathways such
as the WNT, Notch, and Hedgehog signaling pathways influence T
cell development (2–4). Interestingly, there is recent evidence that
these major developmental pathways also control the differentia-
tion of peripheral T cells. Thus, Notch regulates the decision of
CD4 T cells between the Th1 vs the Th2 fate (5), while the Hedge-
hog pathway can influence the proliferation and cytokine produc-
tion of human peripheral CD4 T cells (6, 7). In contrast, it is
currently unknown whether the WNT pathway has any role in
mature T cells.
The canonical WNT signaling pathway is a critical regulator of
stem cell function, e.g., it controls the maintenance and self-re-
newal of hemopoietic stem cells (8–11). Furthermore, dysregula-
tion of the WNT pathway commonly occurs in human cancers
(11). In the absence of a WNT signal, cytoplasmic -catenin is
phosphorylated and targeted for degradation by the proteasome
(3, 11). WNT signaling allows -catenin to escape proteasomal
degradation and to translocate to the nucleus. In the nucleus,
-catenin interacts with members of the lymphoid enhancer
binding factor (LEF)/T cell factor (TCF) family of transcription
factors (LEF1, TCF7 (TCF-1), TCF7L1 (TCF-3), and TCF7L2
(TCF-4)) to activate the transcription of WNT target genes such
as c-myc and cyclin D1 (11). In the absence of WNT signaling,
i.e., when not interacting with -catenin, LEF/TCF family
members act as transcriptional repressors by recruiting Groucho
repressor proteins (12).
LEF1 and TCF7 (TCF-1) share common protein motifs, in par-
ticular, the C-terminal HMG domain of both proteins is responsi-
ble for DNA binding, while a -catenin-binding domain at the N
terminus mediates the interaction with -catenin (12). Interest-
ingly, there are multiple LEF1 and TCF7 (TCF-1) protein isoforms
with distinct functional properties (13–17). In addition to the stim-
ulatory full-length isoforms, there are N-terminally truncated iso-
forms that are without the -catenin-binding domain (referred to as
CTNNB) but retain the ability to interact with Groucho repres-
sors (12). Importantly, these truncated isoforms can function in a
dominant-negative manner in the WNT signaling pathway as has
been demonstrated for CTNNB isoforms of LEF1 (17, 18), TCF7
(TCF-1) (19, 20), and the Xenopus homolog of LEF1/TCF7
(TCF-1) (21). Finally, there are also LEF1 and TCF7 (TCF-1)
isoforms with alternative C-termini (termed tails) known as N- or
B-tailed isoforms. Currently, very little is known about the differ-
ent functional properties of these multiple LEF1 and TCF7
(TCF-1) isoforms in T cells.
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Knockout and transgenic studies in mice have clearly shown a
redundant and -catenin-dependent role of LEF1 and TCF7
(TCF-1) in T cell development (3). TCF7 (TCF-1)/ mice have
impaired T cell development with a partial block at the interme-
diate single-positive to double-positive transition due to reduced
thymocyte proliferation and survival (22–24). Although T cell de-
velopment is normal in LEF1 / mice, B cell development is
impaired (25). Thymocytes from TCF7 (TCF-1)/ LEF1 /
mice show a profound block at the intermediate single-positive
stage with neither double-positive nor single-positive thymocytes
present, and consequently no mature T cells in the periphery (26).
Taken together, the WNT--catenin-LEF1/TCF7 (TCF-1) axis
plays a pivotal role in T cell development. However, it is unknown
whether LEF1, TCF7 (TCF-1), and the WNT pathway have a spe-
cific function in peripheral T cells.
Therefore, we undertook a detailed analysis of the expression of
LEF1 and TCF7 (TCF-1) in human peripheral T cells. We found
that both LEF1 and TCF7 (TCF-1) are expressed in mature CD8
TN and that their expression is down-regulated following TCR or
IL-15R engagement in vitro and Ag encounter in vivo. Further-
more, T cell activation changed the balance of stimulatory vs in-
hibitory LEF1 and TCF7 (TCF-1) isoforms. Our results suggest
that the WNT pathway, in addition to its well-known role in T cell
development, is likely to be involved in regulating peripheral T
cell differentiation.
Materials and Methods
Isolation of CD8 T cell subsets
For microarray and quantitative RT-PCR (qRT-PCR) experiments, CD8 T
cell subsets were isolated from healthy donors in accordance with institu-
tional ethics approval as previously described (27). CD8 T cells were
sorted into either TN (CCR7CD45RA) and effector memory T cells/
effector memory RA T cells (TEM/EMRA; CCR7CD45RA/) (microarray
data set 1), or TN (CCR7CD45RA), central memory T cells (TCM;
CCR7CD45RA), TEM (CCR7CD45RA), and TEMRA
(CCR7CD45RA) populations (microarray data set 2).
Microarray gene expression analysis
RNA extraction and labeling was performed as previously described (27,
28). For microarray data set 1, total RNA was pooled from several donors
(replicate pool 1: n  10; replicate pool 2: n  6) and hybridized to
Affymetrix HG-U95Av2 arrays. Two independent microarray experiments
were performed with RNA from CD8 TN and TEM/EMRA for data set 1.
For microarray data set 2 (described in Ref. 27), total RNA from individual
donors was used and hybridized to Affymetrix HG-U133 plus 2.0 arrays
(Affymetrix). Four independent microarray experiments were performed
with RNA from CD8 TN, TCM, TEM, and TEMRA for data set 2. We used
GCOS software (Affymetrix) and the software package BRB-ArrayTools
for data analysis and the identification of differentially expressed genes
between CD8 T cells subsets (27).
qRT-PCR analysis
qRT-PCR was conducted on cDNA from the indicated CD8 T cell popu-
lations with the 5 nuclease/TaqMan assay. Briefly, we prepared cDNA
from 1 g of DNase-treated total RNA using the SuperScript First-
Strand Synthesis System (Invitrogen Life Technologies). We then per-
formed quantitative PCR in a final volume of 25 l with 300 nM of the
forward and reverse primers and 100–250 nM of the fluorogenic TaqMan
probes (Eurogentec) using 2 quantitative PCR Mastermix Plus (Euro-
gentec). Reactions were run on an ABI Prism 7700 Sequence Detection
System machine (Applied Biosciences) in triplicate (initial steps: 50°C/2
min and 95°C/10 min, followed by 40 cycles: 95°C/15 s and 60°C/1 min)
The following primers and probes were used: 1) LEF1: forward, TGA
CAGCTGCCTACATCTGAAAC; reverse, GCTGCCTTGGCTTTGCAC;
probe: FAM-TGGTGGAAAACGAAGCTCATTCCCAA-TAMRA. LEF1
primers and probes target exon 11/exon 12 and are specific for all LEF1
N-tail isoforms. 2) TCF7 (TCF-1): forward, TGCAGCTATACCCAG
GCTGG; reverse, CCTCGACCGCCTCTTCTTC; probe: FAM-TCCCG
TAGTTGTCCCGCGCTG-TAMRA. TCF7 (TCF-1) primers and probes
target exon 7/exon 8 and are specific for all TCF7 (TCF-1) isoforms. 3)
hypoxanthine phosphoribosyltransferase: forward, GACTTTGCTTTCCT
TGGTCAGG; reverse, AGTCTGGCTTATATCCAACACTTCG; probe:
FAM-TTTCACCAGCAAGCTTGCGACCTTGAC-TAMRA. All probes
span exon-intron junctions. We applied the comparative threshold cycle
method for relative quantification of mRNA expression according to the
manufacturer’s recommendations. Validation experiments demonstrated
that the amplification efficiencies of LEF1 and TCF7 (TCF-1) were equal
to that of the endogenous control hypoxanthine phosphoribosyltransferase.
Intracellular FACS staining
We analyzed intracellular expression of LEF1 and TCF7 (TCF-1) in CD8
T cell subsets using the methanol permeabilization protocol as previously
described (27). LEF1 and TCF7 (TCF-1) were detected by indirect staining
using pretitrated mAbs REMB6 (Oncogene Research Products) and 7H3
(Upstate Biotechnology), respectively. Briefly, 2 g of primary mAb was
added to 2  106 cells and incubated for 1 h at room temperature. After
washing, this was followed by staining with PE-conjugated rabbit anti-
mouse Ab (DakoCytomation) for 1 h at room temperature. Cells were
subsequently washed in blocking buffer (PBS containing 2% mouse serum)
before surface staining with directly conjugated mAbs specific for CD62
ligand (CD62L), CD45RA, and CD8 (all BD Biosciences). CD62L was
used instead of CCR7 as a surface marker because CCR7 staining was
compromised following methanol permeabilization (27).
Stimulation of cord blood (CB) CD8 T cells in vitro
We obtained CB samples from the John Radcliffe Hospital maternity unit,
upon written consent and approval by the local Medical Ethics Committee.
CB CD8 T cells were isolated by immunomagnetic selection as described
above. Phenotyping was conducted using mAbs specific for CCR7 (R&D
Systems), CD45RA (BD Biosciences), CD8 (BD Biosciences), CD3,
CD25, and HLA class II (all DakoCytomation). We stimulated CB CD8 T
cells (1–2  106/ml) with either plate-bound anti-CD3 mAb OKT3 (1
g/well), IL-15 (50 ng/ml), or TGF1 (3 ng/ml) in 24-well plates for the
indicated time points. All cytokines were from obtained R&D Systems.
Cells were cultured in complete medium (RPMI 1640 supplemented with
10% FCS, 1% sodium pyruvate, 2 mM L-glutamine, 100 U/ml penicillin,
and 100 g/ml streptomycin) at 37°C in 5% CO2. Alternatively, CD8 T
cells (1  106) were cocultured with irradiated allogeneic EBV-trans-
formed B cells at a 1:1 ratio. From day 3 onward, CD3 cells represented
95% of live cells in these cocultures, i.e., the stimulator B cells had
practically disappeared.
Cloning of LEF1 mRNA isoforms from primary CD8 T cells
Total RNA was extracted from primary CD8 T cells using TRI Reagent
(Sigma-Aldrich) and cDNA was prepared as described above for the qRT-
PCR experiments. RT-PCR was performed with the following primers:
forward primers, CAGCGGAGCTCAGATTACAGAG (full-length iso-
forms) and ACTCGAGCTCTTCCGGGTACATAATG (CTNNB iso-
forms); reverse primers, CTTCGAATTCCACCATGTTTCAGATG (N-
tail isoforms) and GTCAGAATTCCTTTGGCGTCGACTG (B-tail
isoforms). PCR products were cloned into the vector pIRES2-EGFP (BD
Clontech) followed by DNA sequencing.
Western blot analysis
We prepared protein lysates from 3 to 5  106 CD8 T cells by washing
the cells in PBS and resuspending them in an equal volume of 2 sample
buffer (100 mM Tris-HCl (pH 6.8), 4% SDS, 8% 2-ME, 0.2% bromphenol
blue, and 20% glycerol). After sonication for 2 20 s and boiling for 5–10
min, protein samples were separated by SDS-PAGE and gels blotted to
nitrocellulose membranes. We performed immunodetection of LEF1 and
TCF7 (TCF-1) with the REMB6 mAb (Exalpha) at a 1/500 dilution and
with the 7H3 mAb (Upstate Biotechnology) at a 1/1000 dilution, respec-
tively. This was followed by incubation with secondary HRP-conjugated
anti-mouse Ig (DakoCytomation) and signal detection with ECL reagent
(BD Amersham). Blots were stripped by incubating the membrane at 50°C
for 30 min in stripping buffer (62.5 mM Tris-HCl (pH 6.7), 2% SDS, and
100 mM 2-MEl) and reprobed with anti--actin mAb AC-15 at a 1/5000
dilution (Sigma-Aldrich).
Statistical analysis
A two-sample, two-tailed t test assuming unequal variances was used to
determine the significance of differences in mRNA expression between two
groups (  0.05). For multigroup comparisons, we applied one-way
ANOVA with post hoc testing using Tukey’s significant difference test
(  0.05).
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Results
CD8 TN down-regulate expression of LEF1 and TCF7 (TCF-1)
upon Ag encounter in vivo
We used microarray technology to screen for genes that are differen-
tially expressed between human TN and Ag-primed CD8 T cells. Our
first, exploratory, microarray data set compared gene expression in
purified CD8 TN (CCR7CD45RA) and CD8 TEM/EMRA
(CCR7CD45RA/) populations using RNA pooled from several
donors. We also generated a more detailed second data set that ana-
lyzed the gene expression profiles of CD8 TN (CCR7CD45RA)
in relation to that of CD8 TCM (CCR7CD45RA), TEM
(CCR7CD45RA), and TEMRA (CCR7CD45RA) subsets. Tech-
nical advances allowed us to use RNA from individual donors instead
of pooled RNA and to perform a greater number of replicate exper-
iments (four instead of two) for the second data set. Furthermore, gene
chips (HG-U133 Plus 2.0 instead of HG-U95Av2) with a greater
number of probes and greater coverage of the human genome were
available for this data set. Using this data set, we have previously
investigated the molecular relationships between TN and memory
(Ag-primed) CD8 T cell subsets and the molecular basis for their
different functional properties (27). We now aimed to examine se-
lected differentially expressed genes in more detail to gain further
insight into the molecular basis of CD8 T cell behavior.
We identified LEF1 as a gene highly expressed in TN, compared
with Ag-primed CD8 T cell subsets. In both microarray data sets,
LEF1 was found to be in the top three most differentially expressed
genes when comparing the different mature CD8 T cell populations
(Table I). Indeed, within data set 2, probe identifications for LEF1
accounted for two of the top three differentially expressed genes.
LEF1 mRNA levels were 5- to 10-fold higher in TN, compared
with the three Ag-experienced subsets, with TCM expressing LEF1
more strongly than TEM and TEMRA (Fig. 1A). Interestingly, we
found that TCF7 (TCF-1) was also expressed at higher levels in
TN, compared with TCM, TEM, and TEMRA (Fig. 1B).
qRT-PCR experiments confirmed the differential expression of
LEF1 and TCF7 (TCF-1) in TN and Ag-primed CD8 T cell subsets
(Fig. 1). We also examined LEF1 and TCF7 (TCF-1) protein ex-
pression in peripheral CD8 T cell subsets by intracellular flow
cytometry. Importantly, as shown in Fig. 2, TN (and TCM) ex-
pressed significantly higher levels of both LEF1 and TCF7
(TCF-1) protein than TEM and TEMRA ( p 	 0.05, one-way
ANOVA/Tukey’s post hoc test). In summary, we found that the
WNT pathway effectors LEF1 and TCF7 (TCF-1) are expressed in
peripheral T cells and that LEF1 is the most differentially ex-
pressed transcription factor between TN and Ag-primed CD8 T cell
subsets.
Expression of LEF1 and TCF7 (TCF-1) in CD8 TN is down-
regulated by TCR signals and IL-15 in vitro
We studied the regulation of LEF1 mRNA expression in peripheral
CD8 T cells in vitro by qRT-PCR. We observed down-regulation
of LEF1 mRNA expression in CD8 T cells in response to TCR
triggering (Fig. 3A). This down-regulation was rapid (within 12 h)
and persisted for 48 h. Stimulation with homeostatic cytokines,
such as IL-15, also lead to a persistent decrease in LEF1 mRNA
levels (Fig. 3B), with IL-2 having a similar effect (data not shown).
In contrast, stimulation with TGF1 increased LEF1 expression in
CD8 T cells, compared with the medium control (Fig. 3C).
To investigate the expression of LEF1 and TCF7 (TCF-1) in
CD8 TN, we used CD8 T cells isolated from CB. CB CD8 T cells
have a predominant CCR7CD45RA phenotype similar to adult
TN (Fig. 4A) with some CCR7CD45RA cells also present. Im-
portantly, it has been shown that CB T cells (including the
CCR7CD45RA subset) are functionally naive (29). CB CD8 T
cells showed strong up-regulation of activation markers such as
CD25 (IL-2R; Fig. 4A) and HLA class II (data not shown) in
response to TCR (allogeneic) stimulation. At later time points,
poststimulation CD8 T cells converted back to a resting state as
shown by the absence of activation marker expression (Fig. 4A).
Similar to bulk peripheral CD8 T cells, we observed down-regu-
lation of LEF1 mRNA expression in CD8 TN (from CB) follow-
ing TCR stimulation as measured by qRT-PCR (Fig. 4B). Impor-
tantly, at the time points examined (more than day 3) allogeneic
stimulator B cells had practically disappeared from the T cell-B
cell cocultures. Interestingly, after the initial down-regulation,
there was a progressive increase in LEF1 mRNA expression at
Table I. LEF1 is among the 10 most differentially expressed genes between TN and Ag-primed CD8 T cell subsetsa
No. GenBank Identification Gene Symbol Description TN TEM/EMRA
Microarray data set 1
1 AB018295 NY-REN-7 NY-REN-7 Ag 93.0 6.6
2 M95178 ACTN1 Actinin 1 376.7 29.4
3 AL049409 LEF1 Lymphoid enhancer-binding factor-1 853.2 65.3
4 D90144 CCL3 MIP-1  66.4 491.0
5 U11276 KLRB1 CD161 232.5 1155.1
6 L31584 CCR7 CCR7 1385.7 238.6
7 X76220 MAL T lymphocyte maturation-associated protein 1242.9 106.9
8 AJ223603 C4.4A GPI-anchored metastasis-associated protein homolog 367.0 41.2
9 AA478904 KLF7 Kruppel-like factor-7 189.2 38.0
10 X02910 TNF TNF- 93.9 704.7
No. GenBank Identification Gene Symbol Description TN TCM TEM TEMRA
Microarray data set 2
1 AA992805 LEF1 Lymphoid enhancer-binding factor-1 421.5 52.4 29.8 28.8
2 AI082078 ACTN1 Actinin, 1 928.9 47.4 25.5 41.4
3 AF294627 LEF1 Lymphoid enhancer-binding factor-1 1666.5 208.2 80.8 111.1
4 NM_014795 ZFHX1B Zinc finger homeobox 1b 20.8 127.0 405.6 708.2
5 NM_006144 GZMA Granzyme A 98.3 503.9 2240.4 2429.5
6 AI636759 SLC15A4 Solute carrier family 15, member 4 108.3 191.6 531.6 1020.8
7 AI356412 LYN v-yes-1 Yamaguchi sarcoma viral-related oncogene homolog 22.0 23.6 85.0 313.1
8 BC004344 MGC29816 Hypothetical protein MGC29816 1181.2 240.1 170.6 169.8
9 AI246687 CTSC Cathepsin C 286.7 529.8 1330.6 1541.0
10 NM_002835 PTPN12 Protein tyrosine phosphatase, non-receptor type 12 65.3 87.5 281.6 718.5
a Listed are the 10 most differentially expressed genes between CD8 T cell subsets. Mean expression values (data set 1: n  2; data set 2: n  4) are shown.
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later time points poststimulation, although it varied between do-
nors. A further set of experiments corroborated these results: in
addition to TCR triggering, homeostatic signals such as IL-15 also
decreased LEF1 and TCF7 (TCF-1) mRNA expression in CD8
TN (from CB) (Fig. 4C). The level of LEF1 down-regulation (5- to
10-fold) was similar to that observed when comparing TN and CD8
T cells primed with Ag in vivo (Fig. 1A). Thus, the signals that
control mature CD8 T cell differentiation, i.e., TCR triggering and
homeostatic cytokines, also regulate the expression of LEF1 and
TCF7 (TCF-1) in CD8 TN.
TCR and IL-15 stimulation of peripheral CD8 T cells lead to a
relative decrease in inhibitory LEF1 and TCF7 (TCF-1) isoform
expression
Several LEF1 and TCF7 (TCF-1) isoforms with different func-
tional properties have been described (13–21), but which of these
different isoforms are expressed in CD8 T cells is unknown. There-
fore, we analyzed LEF1 and TCF7 (TCF-1) isoform expression in
mature T cells. First, cloning of LEF1 mRNA isoforms by RT-
PCR and DNA sequencing showed that peripheral CD8 T cells
express both stimulatory full-length and inhibitory CTNNB
LEF1 mRNA isoforms (Fig. 5A). Furthermore, we found that CD8
T cells preferentially express N-tail LEF1 mRNA isoforms, al-
though isoforms carrying a B-tail could also be detected (Fig. 5B).
These mRNA isoforms were distinguished by the presence (N-tail
isoforms) or absence (B-tail isoforms) of exon 11 (16). The pre-
dominance of N-tail isoforms applied to both full-length and CT-
NNB LEF1 mRNA isoforms (Fig. 5B).
Second, we investigated LEF1 and TCF7 (TCF-1) protein iso-
form expression by Western blot. Jurkat cells, a transformed im-
mature T cell line with a high proliferative capacity, predominantly
expressed stimulatory full-length LEF1 isoforms of 48–55 kDa
(Fig. 6A) as previously reported (17). In contrast, primary resting
CD8 T cells showed predominant expression of a 38-kDa LEF1
protein isoform (Fig. 6A). It has previously been demonstrated that
this 38-kDa LEF1 band corresponds to the CTNNB LEF1 iso-
form that has a dominant-negative function in the WNT signaling
pathway (17, 18). The predominance of inhibitory LEF1 protein
isoforms also applied to resting CD8 TN (from CB; Fig. 6B, lane
1). In line with our mRNA expression results (Fig. 4), there was an
overall down-regulation of LEF1 protein expression following
TCR triggering or stimulation with IL-15 in vitro (Fig. 6B, lanes 2
and 3).
FIGURE 1. CD8 TN down-regulate expression of LEF1 and TCF7
(TCF-1) mRNA upon Ag encounter in vivo. Upper panels, Expression of
LEF1 (A) and TCF7 (TCF-1) (B) mRNA as examined in TN
(CCR7CD45RA) and TEM/TEMRA (CCR7CD45RA/) CD8 T cell sub-
sets by microarray analysis (data set 1, n  2) and qRT-PCR (n  4). , p 	
0.05 (two-sample t test with unequal variances), compared with TN. In the
second microarray data set (lower panels), LEF1 (A) and TCF7 (TCF-1) (B)
mRNA expression was determined in TN (CCR7CD45RA), TCM
(CCR7CD45RA), TEM (CCR7CD45RA), and TEMRA
(CCR7CD45RA) subsets from four individual donors. LEF1 and TCF7
(TCF-1) mRNA expression relative to TN is displayed. , p 	 0.05 (one-way
ANOVA, Tukey’s significant difference post hoc test), compared with TN.
FIGURE 2. Intracellular LEF1 and TCF7 (TCF-1) protein expression in
TN and Ag-primed CD8 T cell subsets. LEF1 (A) and TCF7 (TCF-1) (B)
protein expression was detected in CD8 T cell subsets by intracellular
FACS staining as described in Materials and Methods. Thin line histo-
grams indicate isotype control staining, thick line histograms LEF1 (A) or
TCF7 (TCF-1) (B) staining. A representative example from one donor is
shown. Similar results were obtained for CD8 T cell subsets from two other
donors.
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Similar to LEF1, we observed differences in the stimulatory vs
inhibitory TCF7 (TCF-1) isoform balance between primary T cells
and transformed Jurkat T cells. Jurkat cells showed predominant
expression of stimulatory full-length TCF7 (TCF-1) isoforms of
42–48 kDa (Fig. 7A). In contrast, the ratio of stimulatory full-
length (42–48 kDa)/inhibitory CTNNB (26–32 kDa) TCF7
(TCF-1) isoforms (14, 15) was about equal in resting (Fig. 7A) and
CD8 TN (from CB; Fig. 7B, lane 1). Clevers and colleagues (15)
have previously demonstrated that the 26- to 32-kDa bands corre-
spond to CTNNB TCF7 (TCF-1) isoforms that have a dominant-
negative function (19, 20). Interestingly, TCR and IL-15 stimula-
tion of CD8 TN (from CB) lead to preferential down-regulation
of the inhibitory TCF7 (TCF-1) CTNNB isoforms (Fig. 7B, lanes
2 and 3). Thus, the TCF7 (TCF-1) protein isoform balance in CD8
T cells changed in favor of the stimulatory isoforms following
activation. In conclusion, our data suggest that the negative effects
of inhibitory LEF1 and TCF7 (TCF-1) isoforms prevail in resting
CD8 T cells. In activated cells this negative effect seems to be
relieved by down-regulation of overall LEF1 protein expression
and by specific down-regulation of inhibitory TCF7 (TCF-1) iso-
form expression.
Discussion
Ag-experienced T cells are better able than TN to respond to Ag.
This reflects both an increase in their frequency and a change in
their state of differentiation. The molecular mechanisms that un-
derpin the changes in cellular state and hence the development of
T cell memory remain poorly understood. The capacity of tran-
scription factors to modulate many different aspects of T cell func-
tion makes them an attractive candidate for study in this respect. In
two separate microarray studies, we observed that the WNT path-
way effector, LEF1, was expressed at higher levels in TN, com-
pared with Ag-experienced CD8 T cells. Indeed, in both studies, it
proved to be one of the most differentially expressed genes and the
most differentially expressed transcription factor between these
two populations of cells. A second effector of the same pathway,
TCF7 (TCF-1), was also differentially expressed.
The differential expression of these molecules in the different
CD8 T cell subsets proved to be consistent and robust; it was
confirmed at the level of mRNA using qRT-PCR and at the level
of protein using intracellular staining in many different donors.
FIGURE 3. TCR signals and IL-15 down-regulate, while TGF1 up-
regulates LEF1 mRNA expression in CD8 T cells. Human CD8 T cells
were isolated by immunomagnetic selection and stimulated with either
plate-bound anti-CD3 mAb/OKT3 at 1 g/well (A), IL-15 at 50 ng/ml (B),
or TGF1 at 3 ng/ml (C). At the indicated time points, LEF1 mRNA
expression was examined by qRT-PCR relative to the resting state ( 0 h).
, p 	 0.05 (two-sample t test with unequal variances), compared with
medium control. Two independent experiments with CD8 T cells from
different donors were performed.
FIGURE 4. TCR and homeostatic signals inhibit expression of LEF1
and TCF7 (TCF-1) in CD8 TN. A, Characterization of CB CD8 T cells.
CD8 T cells were isolated from CB and their CCR7/CD45RA phenotype
examined by FACS. A representative example from one donor is shown
(left panel). The right panel shows expression of the activation marker
CD25 (IL-2R) in resting CD8 T cells (day (d), d0), thin line histogram)
and in cells poststimulation with alloantigen (d6, thick line histogram; d14,
thin line histogram). B
,
LEF1 mRNA expression in response to allogeneic
stimulation of CD8 TN. CB CD8 T cells (A) were stimulated with irra-
diated allogeneic EBV-transformed B cells and LEF1 mRNA expression
was determined by qRT-PCR at the indicated time points. Results from
three independent experiments are shown. , p 	 0.05 (one-way ANOVA,
Tukey’s significant difference post hoc test), compared with day 0. C, Ex-
pression of LEF1 and TCF7 (TCF-1) mRNA in response to alloantigen and
IL-15. CD8 TN (from CB) were stimulated with either IL-15 at 50 ng/ml
or with irradiated allogeneic EBV-transformed B cells for 5 days. Relative
expression of LEF1 and TCF7 (TCF-1) as determined by qRT-PCR is
shown for one of three independent experiments. , p 	 0.05 (two-sample
t test with unequal variances), compared with day 0.
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Furthermore, in a longitudinal study in an in vitro system, we were
able to show that stimulation of TN, by alloantigen, led to a down-
regulation of LEF1 and TCF7 (TCF-1).
The importance of these two transcription factors in regulating
thymocyte development is accepted. Their possible role in regu-
lating peripheral T cell function has not been considered previ-
ously. TN can be regarded as peripheral stem cells, while TEM and
TEMRA are differentiated cells with effector function. The idea that
expression of LEF1 and TCF7 (TCF-1) may be relevant to main-
taining the TN stem cell population is in line with the known role
of the WNT--catenin-LEF1/TCF7 (TCF-1) pathway in the main-
tenance of hemopoietic stem cells (8–11). The observation that
peripheral T cells from TCF7 (TCF-1)/ mice have a spontane-
ously activated phenotype (CD44highCD62Llow) that is character-
istic of Ag-primed cells is also in line with this notion (23).
Our results are most consistent with the idea that LEF1 and
TCF7 (TCF-1) might control T cell quiescence. Similar to TCR
signals, we observed that other pro-proliferative signals such as the
cytokines IL-2 and IL-15 inhibit LEF1 and TCF7 (TCF-1) expres-
sion. Interestingly, it has been shown that IL-15 and TCR stimu-
lation induce very similar changes in gene expression in human
CD8 T cells (30). This would suggest that IL-15 and TCR stimu-
lation probably activate common signaling pathways, and this
could also apply to the regulation of LEF1/TCF7 (TCF-1) expres-
sion in CD8 T cells. Furthermore, one recent study reported that
another IL-2 family member, IL-7, can also inhibit LEF1 and
TCF7 (TCF-1) expression (31). In contrast, we found that TGF1,
which is known to inhibit T cell differentiation and maintain T cell
quiescence (32), increased LEF1 expression. Interestingly, we
noted a partial recovery of LEF1 expression in CD8 T cells in vitro
when the cells converted back to a resting state following Ag stim-
ulation. Similarly, one murine microarray study demonstrated ini-
tial down-regulation/partial recovery of LEF1 expression upon
naive3 effector3 memory CD8 T cell differentiation in
vivo (33).
The observed correlations between expression of LEF1 and
TCF7 (TCF-1) and T cell naivety and quiescence were not con-
sistent with published data showing that LEF1 and TCF7 (TCF-1)
are able to drive cellular proliferation. However, this paradox was
resolved by additional experiments that analyzed the expression of
the different LEF1 and TCF7 (TCF-1) isoforms. Our work shows
that, compared with Jurkat cells, resting CD8 T cells express rel-
atively more of the inhibitory LEF1 and TCF7 (TCF-1) protein
isoforms. T cell stimulation results in down-regulation of this in-
hibitory isoform. Importantly, it has previously been shown that
although stimulatory full-length LEF1 and TCF7 (TCF-1) iso-
forms drive the proliferation of Jurkat T cells, dominant-negative
CTNNB isoforms inhibit proliferation (20). Furthermore, colon
cancer cells predominantly express full-length LEF1 isoforms
while down-regulating the expression of CTNNB isoforms (17).
Finally, inhibitory CTNNB isoforms are the most abundant
TCF7 (TCF-1) isoforms in the intestine and TCF7 (TCF-1)/
mice develop intestinal and mammary adenomas (19). Thus, it is
been suggested that the balance between stimulatory and inhibitory
FIGURE 5. Expression of different LEF1 isoforms in primary CD8 T
cells. A, Cloning of LEF1 isoforms from CD8 T cells. LEF1 mRNA iso-
forms were amplified from primary human CD8 T cells by RT-PCR using
primers specific for either full-length or CTNNB isoforms. Left panel,
Gel electrophoresis of LEF1 PCR products. First lane on the left, DNA
marker; and second lane, no template control. LEF1 PCR products were
ligated into the vector pIRES2-EGFP and analyzed by restriction digestion
(right panel). First lane on left, DNA marker; second lane, undigested
parental vector (pIRES2-EGFP); and third lane, digested parental vector;
lanes 1–4, digested pIRES2-LEF1. B, CD8 T cells predominantly express
N-tail LEF1 mRNA isoforms. DNA sequencing results for cloned LEF1
mRNA isoforms from A are displayed. The number of clones identical with
a specific isoform among all of the clones sequenced is given in
parentheses.
FIGURE 6. CD8 TN preferentially express inhibitory LEF1 isoforms
and down-regulate LEF1 protein expression upon activation. A, Primary
resting T cells show preferential expression of inhibitory LEF1 protein
isoforms. Expression of full-length and truncated (CTNNB) LEF1 protein
isoforms in the Jurkat T cell line and in primary human CD8 T cells was
examined by Western blotting. B, Down-regulation of LEF1 protein ex-
pression in activated CD8 T cells. CD8 TN (from CB) were either left
unstimulated (lane 1) or stimulated with IL-15 at 50 ng/ml (lane 2) or
alloantigen (lane 3). LEF1 protein expression was analyzed by Western
blotting. Blotting with -actin Ab (bottom panel) was used to assess pro-
tein loading. Two independent experiments are shown.
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LEF1 and TCF7 (TCF-1) is a checkpoint for cellular proliferation
in the context of malignancy.
In a conceptually similar way, the experiments we describe lead
us to formulate the hypothesis that the balance between stimula-
tory and inhibitory LEF1 and TCF7 (TCF-1) isoforms represent a
checkpoint for the quiescence of peripheral T cells. Direct evi-
dence for this will require future studies, in which expression of
individual LEF1 and TCF7 (TCF-1) isoforms or combinations of
individual isoforms is manipulated in primary mature T cells. The
functional redundancy between LEF1 and TCF7 (TCF-1) and the
presence of numerous isoforms will make such experiments diffi-
cult to design and perform. Consistent with this, in preliminary
experiments, we did not find a clear phenotype when knocking
down total LEF1 (i.e., all isoforms) by RNA interference in human
peripheral T cells. Studies in knockout and transgenic mice are
probably more suited to address the role of the WNT pathway in
mature T cells, although the conditional knockout of individual
LEF1 and TCF7 (TCF-1) isoforms will be challenging.
In conclusion, our study identifies LEF1 as the most differen-
tially expressed transcription factor between TN and Ag-experi-
enced CD8 T cells. It shows that, compared with a Jurkat cell line,
CD8 TN express more of the inhibitory isoform of this and an-
other (TCF7 (TCF-1)) member of the WNT signaling pathway. We
provide evidence that down-regulation of these inhibitory isoforms
is associated with T cell stimulation. Our results suggest that the
WNT pathway may have a specific function not only in immature,
but also in mature T cells and provide a strong rationale for further
molecular studies aimed at directly investigating the functional
importance of individual isoforms of members of the WNT-LEF1/
TCF7 (TCF-1) signaling pathway in peripheral T cell
differentiation.
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